Learn More
Invitrogen™ CD85g (ILT7) Monoclonal Antibody (eBio17G10.2 (17G10.2)), APC, eBioscience™
Mouse Monoclonal Antibody
£225.00
Specifications
| Antigen | CD85g (ILT7) |
|---|---|
| Clone | eBio17G10.2 (17G10.2) |
| Concentration | 5 μL/Test |
| Content And Storage | 4°C, store in dark, DO NOT FREEZE! |
| Applications | Flow Cytometry |
Description
Description: The eBio17G10.2 monoclonal antibody reacts with human immunoglobulin-like transcript 7 (ILT7), also known as CD85g. ILT7 is part of the leukocyte immunoglobulin-like receptor (LIR) gene family and associates with FcεR1gamma to form a functional complex which transduces ITAM-mediated signals that negatively modulates TLR-induced type I IFN production by human plasmacytoid dendritic cells. ILT7 is expressed exclusively on plasmacytoid dendritic cells and is absent in monocyte derived DCs. Treatment with IL-3 or CpG causes a decrease in expression. Double staining of human PBMCs with eBio17G10.2 and anti-pDC marker BDCA2 yields virtually complete co-staining. Cross linking of ILT7 with eBio17G10.2 antibody causes reduced transcription of IFN-alpha1, IFN-alpha2, IFN-alpha4 and IFN-beta. Applications Reported: This eBio17G10.2 (17G10.2) antibody has been reported for use in flow cytometric analysis. Applications Tested: This eBio17G10.2 (17G10.2) antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells. This can be used at 5 μL (0.25 μg) per test. A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. Excitation: 633-647 nm; Emission: 660 nm; Laser: Red Laser. Filtration: 0.2 μm post-manufacturing filtered.
ILT7 is a pDC-specific IgG-like transcript and is a member of the leukocyte immunoglobulin-like receptor gene family. This receptor, in complex with FcER1a, transduces ITAM-mediated signals which negatively modulate type I IFN production by pDC. ILT7 is thus a potential target to regulate Type 1 IFN production by pDC, which play a major role during viral infection, auto-immune diseases and anti-cancer immunity. Additionally, ILT7, along with CD123 and BDCA-2, can be used to identify or classify subsets of pDCalong with TLR expression and TLR mediated immune responses.Specifications
| CD85g (ILT7) | |
| 5 μL/Test | |
| Flow Cytometry | |
| APC | |
| Mouse | |
| RUO | |
| PBS with BSA and 0.09% sodium azide; pH 7.2 | |
| P59901 | |
| 23547 | |
| Primary | |
| Affinity chromatography |
| eBio17G10.2 (17G10.2) | |
| 4°C, store in dark, DO NOT FREEZE! | |
| Monoclonal | |
| Liquid | |
| IgG1 | |
| Human | |
| LILRA4 | |
| CD85 antigen-like family member G; CD85g; ILT7; ILT-7; Immunoglobulin-like transcript 7; leucocyte Ig-like receptor A4; leukocyte immunoglobulin like receptor A4; leukocyte immunoglobulin-like receptor subfamily A member 4; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4; LILRA4 | |
| LILRA4 | |
| Antibody |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.